JP2009227680A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009227680A5 JP2009227680A5 JP2009119505A JP2009119505A JP2009227680A5 JP 2009227680 A5 JP2009227680 A5 JP 2009227680A5 JP 2009119505 A JP2009119505 A JP 2009119505A JP 2009119505 A JP2009119505 A JP 2009119505A JP 2009227680 A5 JP2009227680 A5 JP 2009227680A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- enterococcal
- carrier
- immunoglobulin
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 15
- 102000036639 antigens Human genes 0.000 claims 15
- 108091007433 antigens Proteins 0.000 claims 15
- 108060003951 Immunoglobulin Proteins 0.000 claims 5
- 102000018358 immunoglobulin Human genes 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 206010014889 Enterococcal infections Diseases 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 239000002955 immunomodulating agent Substances 0.000 claims 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 2
- 229960003983 diphtheria toxoid Drugs 0.000 claims 2
- 239000002158 endotoxin Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 231100000252 nontoxic Toxicity 0.000 claims 2
- 230000003000 nontoxic effect Effects 0.000 claims 2
- 238000005215 recombination Methods 0.000 claims 2
- 230000006798 recombination Effects 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 241000194032 Enterococcus faecalis Species 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- OVRNDRQMDRJTHS-KEWYIRBNSA-N N-acetyl-D-galactosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-KEWYIRBNSA-N 0.000 claims 1
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- 230000001761 anti-enterococcal effect Effects 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 229930182830 galactose Natural products 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- NVLRFXKSQQPKAD-UHFFFAOYSA-N tricarbon Chemical compound [C]=C=[C] NVLRFXKSQQPKAD-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/949,757 US6756361B1 (en) | 1997-10-14 | 1997-10-14 | Enterococcus antigens and vaccines |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000515628A Division JP2001519402A (ja) | 1997-10-14 | 1998-10-14 | 腸球菌抗原およびワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009227680A JP2009227680A (ja) | 2009-10-08 |
| JP2009227680A5 true JP2009227680A5 (enExample) | 2010-08-12 |
Family
ID=25489514
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000515628A Pending JP2001519402A (ja) | 1997-10-14 | 1998-10-14 | 腸球菌抗原およびワクチン |
| JP2009119505A Pending JP2009227680A (ja) | 1997-10-14 | 2009-05-18 | 腸球菌抗原およびワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000515628A Pending JP2001519402A (ja) | 1997-10-14 | 1998-10-14 | 腸球菌抗原およびワクチン |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6756361B1 (enExample) |
| EP (3) | EP2269635A1 (enExample) |
| JP (2) | JP2001519402A (enExample) |
| AT (1) | ATE397456T1 (enExample) |
| AU (1) | AU754890B2 (enExample) |
| BR (1) | BR9813254A (enExample) |
| CA (1) | CA2306476A1 (enExample) |
| CY (1) | CY1108307T1 (enExample) |
| DE (1) | DE69839587D1 (enExample) |
| DK (1) | DK1028749T3 (enExample) |
| ES (1) | ES2308818T3 (enExample) |
| NZ (1) | NZ504501A (enExample) |
| PT (1) | PT1028749E (enExample) |
| WO (1) | WO1999018996A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6905670B2 (en) | 1995-03-28 | 2005-06-14 | The General Hospital Corporation | Methods of screening compounds useful for prevention of infection or pathogenicity |
| KR100217772B1 (ko) * | 1996-09-03 | 1999-09-01 | 최진호 | 조명기기의 램프 과열방지 장치 및 방법 |
| US6756361B1 (en) * | 1997-10-14 | 2004-06-29 | Nabi | Enterococcus antigens and vaccines |
| US7078584B2 (en) | 2000-03-17 | 2006-07-18 | The General Hospital Corporation | Salmonella typhimurium-infected Caenorhabditis elegans for identifying inhibitors of infection |
| US7112716B2 (en) | 2000-04-06 | 2006-09-26 | The General Hospital Corporation | Methods for screening and identifying host pathogen defense genes |
| US6710403B2 (en) | 2002-07-30 | 2004-03-23 | Fairchild Semiconductor Corporation | Dual trench power MOSFET |
| US20080175856A1 (en) * | 2003-05-30 | 2008-07-24 | Intercell Ag | Enterococcus Antigens |
| EP2583678A3 (en) | 2004-06-24 | 2013-11-13 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
| CA2575548A1 (en) | 2004-07-29 | 2006-07-27 | John L. Telford | Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| AU2005324448A1 (en) * | 2005-01-10 | 2006-07-20 | Glaxosmithkline Biologicals Sa | Method of treating Staphylococcus aureus infection |
| JP2009511636A (ja) | 2005-10-18 | 2009-03-19 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド | アルファウイルスレプリコン粒子による粘膜免疫および全身免疫 |
| US7527801B2 (en) | 2005-11-22 | 2009-05-05 | Novartis Vaccines And Diagnostics, Inc. | Norovirus and Sapovirus antigens |
| WO2008019162A2 (en) | 2006-01-18 | 2008-02-14 | University Of Chicago | Compositions and methods related to staphylococcal bacterium proteins |
| CA2647100A1 (en) * | 2006-03-23 | 2007-09-27 | Novartis Ag | Methods for the preparation of imidazole-containing compounds |
| US8173657B2 (en) * | 2006-03-23 | 2012-05-08 | Novartis Ag | Imidazoquinoxaline compounds as immunomodulators |
| WO2007109812A2 (en) * | 2006-03-23 | 2007-09-27 | Novartis Ag | Immunopotentiating compounds |
| EP3018142A1 (en) | 2006-06-06 | 2016-05-11 | Crucell Holland B.V. | Human binding molecules having killing activity against staphylococci and uses thereof |
| JP5586952B2 (ja) | 2006-06-06 | 2014-09-10 | クルセル ホランド ベー ヴェー | 腸球菌に対する殺活性を有するヒトの結合分子及びその使用方法 |
| JP5658564B2 (ja) | 2007-08-31 | 2015-01-28 | ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ | ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物 |
| JP5653215B2 (ja) | 2007-09-12 | 2015-01-14 | ノバルティス アーゲー | Ｇａｓ５７変異体抗原およびｇａｓ５７抗体 |
| EP2537857B1 (en) | 2007-12-21 | 2017-01-18 | GlaxoSmithKline Biologicals SA | Mutant forms of streptolysin O |
| AU2009302582A1 (en) | 2008-10-06 | 2010-04-15 | University Of Chicago | Compositions and methods related to bacterial Eap, Emp, and/or AdsA proteins |
| NZ594029A (en) | 2009-01-12 | 2014-01-31 | Novartis Ag | Cna_b domain antigens in vaccines against gram positive bacteria |
| HUE026855T2 (en) | 2009-04-03 | 2016-07-28 | Univ Chicago | Compositions and methods related to protein a (spa) variants |
| EP2443250B8 (en) | 2009-06-16 | 2016-09-21 | GlaxoSmithKline Biologicals SA | High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays |
| US10266585B2 (en) | 2009-08-28 | 2019-04-23 | The Board Of Regents Of The Univerity Of Texas System | Methods of treating brain injury |
| AU2010342872B2 (en) * | 2010-01-19 | 2014-09-25 | Universitatsklinikum Freiburg | Enterococcal cell wall components and antibacterial use thereof |
| EP2555794A4 (en) | 2010-04-05 | 2014-01-15 | Univ Chicago | COMPOSITIONS AND METHODS RELATING TO PROTEIN A (SPA) ANTIBODIES AS IMMUNE REACTION AMPLIFIERS |
| KR20130121699A (ko) | 2010-05-28 | 2013-11-06 | 테트리스 온라인, 인코포레이티드 | 상호작용 혼성 비동기 컴퓨터 게임 기반구조 |
| SG186290A1 (en) | 2010-07-02 | 2013-01-30 | Univ Chicago | Compositions and methods related to protein a (spa) variants |
| EP2614074A1 (en) | 2010-09-09 | 2013-07-17 | The University of Chicago | Methods and compositions involving protective staphylococcal antigens |
| WO2012051498A2 (en) | 2010-10-15 | 2012-04-19 | The Board Of Regents Of The University Of Texas System | Antibodies that bind amyloid oligomers |
| US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| EP2526951B1 (en) * | 2011-05-27 | 2015-09-30 | Universitätsklinikum Freiburg | Rhamno-polysaccharide from Enterococcus faecium clonal complex 17 and uses thereof |
| BR112014003315A2 (pt) | 2011-08-15 | 2017-03-01 | Univ Chicago | composições e métodos relacionados a anticorpos para a proteína a estafilocócica |
| CA2910320A1 (en) | 2012-04-26 | 2013-10-31 | University Of Chicago | Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease |
| BR112014026861A2 (pt) | 2012-04-26 | 2018-05-15 | Univ Chicago | antígenos de estafilococos coagulase e métodos de seu uso |
| WO2014013375A1 (en) | 2012-07-16 | 2014-01-23 | Pfizer Inc. | Saccharides and uses thereof |
| WO2014116721A1 (en) | 2013-01-22 | 2014-07-31 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Geminiviral vector for expression of rituximab |
| EP2915543B1 (en) * | 2014-03-04 | 2018-05-09 | Albert-Ludwigs-Universität Freiburg | Polypeptides derived from Enterococcus and their use for vaccination and the generation of therapeutic antibodies |
| WO2017173398A1 (en) | 2016-04-01 | 2017-10-05 | Duke University | Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform |
| US11413336B2 (en) | 2018-03-23 | 2022-08-16 | Board Of Regents, The University Of Texas System | Coccidioides antigens and methods of their use |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2466251B1 (fr) * | 1979-10-03 | 1983-03-18 | Agronomique Inst Nat Rech | Vaccin animal anticolibacillaire, obtention et application |
| US4439422A (en) | 1980-01-02 | 1984-03-27 | Research Corporation | Group B Streptococcus antigens and vaccines |
| US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| JPS5927833A (ja) * | 1982-08-06 | 1984-02-14 | Advance Res & Dev Co Ltd | コレステロール乃至トリグリセリド低下剤 |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| FR2546756B1 (fr) * | 1983-06-03 | 1985-11-29 | Centre Nat Rech Scient | Nouveaux derives immunostimulants, leur preparation et leur application comme medicament |
| US4761283A (en) * | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
| JPS6028401A (ja) | 1983-07-27 | 1985-02-13 | Advance Res & Dev Co Ltd | トリグリセリド低下活性多糖類 |
| US4626502A (en) * | 1984-01-27 | 1986-12-02 | Abbott Laboratories | Method for exposing bacterial antigen in bacterial cells assay using same |
| US4695624A (en) | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
| GB8414273D0 (en) * | 1984-06-05 | 1984-07-11 | Oxoid Ltd | Identifying streptococcal grouping |
| JPS615022A (ja) * | 1984-06-19 | 1986-01-10 | Advance Res & Dev Co Ltd | 腸内細菌叢改善剤 |
| GB8517895D0 (en) * | 1985-07-16 | 1985-08-21 | Technology Licence Co Ltd | Monoclonal antibodies |
| US4695524A (en) * | 1986-05-21 | 1987-09-22 | Xerox Corporation | Process for ultra high quality images with magnetic developer composition |
| US5143845A (en) * | 1986-09-03 | 1992-09-01 | Toa Pharmaceutical Co., Ltd. | Mixture of saccarifying lactic acid producing and butyric acid producing bacteria |
| CA1301645C (en) * | 1986-10-08 | 1992-05-26 | David Bernstein | Method for exposing group a streptococcal antigens and an improved diagnostictest for the identification of group a streptococci |
| US5032505A (en) | 1988-11-21 | 1991-07-16 | Chembiomed, Ltd. | Inhibitors for glycosaminosyl transferase V |
| US5175279A (en) * | 1989-01-19 | 1992-12-29 | Hakuto Co., Ltd. | Polysaccharide, and water absorbent, moisture absorbent or humectant and thickening agent chiefly made of the polysaccharide |
| US5032401A (en) * | 1989-06-15 | 1991-07-16 | Alpha Beta Technology | Glucan drug delivery system and adjuvant |
| US5010062A (en) * | 1989-09-25 | 1991-04-23 | Vanderbilt University | Therapeutic agent and method of inhibiting vascularization of tumors |
| CA2059692C (en) | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
| US5858728A (en) * | 1991-03-13 | 1999-01-12 | Common Services Agency | Monoclonal antibody against LPS core |
| US5225331A (en) * | 1991-04-25 | 1993-07-06 | National Research Council Of Canada | Immunoassay for detecting group b streptococcus |
| US5205917A (en) * | 1991-05-07 | 1993-04-27 | Glyko, Inc. | Fluorophore assisted carbohydrate electrophoresis diagnosis |
| US5651968A (en) * | 1991-08-23 | 1997-07-29 | Alberta Research Council | Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients |
| US5478557A (en) * | 1992-07-29 | 1995-12-26 | The United States Of America, As Represented By The Secretary Of Agriculture | Probiotic for control of salmonella |
| RU2101029C1 (ru) * | 1992-11-26 | 1998-01-10 | Товарищество с ограниченной ответственностью "ХИМЭК" | Способ получения препарата для идентификации стрептококка группы д |
| GB9310468D0 (en) * | 1993-05-20 | 1993-07-07 | Oxford Glycosystems Ltd | Sugar complexes |
| US5367058A (en) * | 1993-08-25 | 1994-11-22 | Becton, Dickinson And Company | Modified antibodies with increased affinity |
| JPH0782158A (ja) * | 1993-09-16 | 1995-03-28 | Yakult Honsha Co Ltd | 抗腫瘍剤 |
| JP2717497B2 (ja) * | 1993-12-28 | 1998-02-18 | 不二ラテックス株式会社 | 酸性多糖類被覆コンドーム |
| GB9401689D0 (en) * | 1994-01-28 | 1994-03-23 | Univ Manchester | Diagnosis and treatment of endocarditis |
| US5866135A (en) * | 1994-04-21 | 1999-02-02 | North American Vaccine, Inc. | Group A streptococcal polysaccharide immunogenic compositions and methods |
| US5489302A (en) * | 1994-05-24 | 1996-02-06 | Skottun; Bernt C. | Accommodating intraocular lens |
| JPH0827010A (ja) * | 1994-07-19 | 1996-01-30 | Nichinichi Seiyaku Kk | 制癌免疫療法剤 |
| US5700787A (en) * | 1994-09-02 | 1997-12-23 | Brigham & Women's Hospital, Inc. | Capsular polysaccharide immunomodulator |
| US5871751A (en) * | 1994-10-12 | 1999-02-16 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Renibacterium salmoninarum vaccine and method for its preparation |
| US5569366A (en) * | 1995-01-27 | 1996-10-29 | Beckman Instruments, Inc. | Fluorescent labelled carbohydrates and their analysis |
| US5760213A (en) * | 1995-06-05 | 1998-06-02 | Tayca Corporation | Immunoactivating agent |
| US5695768A (en) * | 1995-06-07 | 1997-12-09 | Alberta Research Council | Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides |
| DE19524515A1 (de) * | 1995-07-05 | 1997-01-09 | Deutsches Krebsforsch | Saccharid-Konjugate |
| US6722062B2 (en) * | 1997-08-20 | 2004-04-20 | The Brigham And Women's Hospital, Inc. | Capsular polysaccharides from enterococci |
| WO1999008705A1 (en) * | 1997-08-20 | 1999-02-25 | Brigham And Women's Hospital | Capsular polysaccharides from enterococci |
| US6756361B1 (en) * | 1997-10-14 | 2004-06-29 | Nabi | Enterococcus antigens and vaccines |
| DK1121135T3 (da) * | 1998-09-14 | 2009-03-23 | Nabi Biopharmaceuticals | Præparater af beta-glucaner og specifikke immunglobuliner |
| US7030101B2 (en) * | 1998-09-14 | 2006-04-18 | Nabi Biopharmaceuticals | Compositions of β-glucans and specific antibodies |
| TR200202066T2 (tr) * | 1999-03-12 | 2004-12-21 | University Of Massachusetts | Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları |
| US6720160B2 (en) * | 2001-10-11 | 2004-04-13 | Helica Biosystems, Inc. | Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals |
-
1997
- 1997-10-14 US US08/949,757 patent/US6756361B1/en not_active Expired - Fee Related
-
1998
- 1998-10-14 AU AU96949/98A patent/AU754890B2/en not_active Ceased
- 1998-10-14 AT AT98951058T patent/ATE397456T1/de active
- 1998-10-14 NZ NZ504501A patent/NZ504501A/en not_active IP Right Cessation
- 1998-10-14 PT PT98951058T patent/PT1028749E/pt unknown
- 1998-10-14 ES ES98951058T patent/ES2308818T3/es not_active Expired - Lifetime
- 1998-10-14 BR BR9813254-7A patent/BR9813254A/pt not_active IP Right Cessation
- 1998-10-14 DK DK98951058T patent/DK1028749T3/da active
- 1998-10-14 EP EP10178313A patent/EP2269635A1/en not_active Withdrawn
- 1998-10-14 JP JP2000515628A patent/JP2001519402A/ja active Pending
- 1998-10-14 WO PCT/US1998/021561 patent/WO1999018996A1/en not_active Ceased
- 1998-10-14 EP EP98951058A patent/EP1028749B1/en not_active Expired - Lifetime
- 1998-10-14 EP EP08008590A patent/EP1970073A1/en not_active Withdrawn
- 1998-10-14 CA CA002306476A patent/CA2306476A1/en not_active Abandoned
- 1998-10-14 DE DE69839587T patent/DE69839587D1/de not_active Expired - Lifetime
-
2004
- 2004-06-28 US US10/876,758 patent/US7291343B2/en not_active Expired - Fee Related
-
2008
- 2008-09-02 CY CY20081100934T patent/CY1108307T1/el unknown
-
2009
- 2009-05-18 JP JP2009119505A patent/JP2009227680A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009227680A5 (enExample) | ||
| JP2001519402A5 (enExample) | ||
| JP6410601B2 (ja) | 抗リポアラビノマンナン抗体及び当該抗体を用いた抗酸菌症のイムノアッセイ | |
| WO1999018996B1 (en) | Enterococcus antigens and vaccines | |
| CA2366433A1 (en) | Staphylococcus antigen and vaccine | |
| CN106659799B (zh) | 用于制备针对因肠致病性细菌引起的感染的广谱疫苗的包含表达内置的多个表位的分子构建体的基本单元的糖缀合物疫苗 | |
| JP2004346084A (ja) | 複数種オリゴ糖の糖接合体型の細菌性髄膜炎ワクチン | |
| WO2012082635A1 (en) | Synthetic oligosaccharide group a streptococcus | |
| JP2009007355A (ja) | 黄色ブドウ球菌抗原 | |
| US20130116423A1 (en) | Synthetic Oligosaccharides for Staphylococcus Vaccine | |
| WO2020201985A1 (en) | Compositions and methods for eliciting an immune response against clostridium difficile | |
| US20090155299A1 (en) | Antibodies for the Detection of Bacillus Anthracis and Vaccine Against B. Anthracis Infections | |
| WO2012145626A1 (en) | Synthetic oligosaccharides for staphylococcus vaccine | |
| CN1150840A (zh) | 一种检测分枝杆菌属细菌存在的方法以及及其所用的试剂盒和抗体 | |
| US10207006B2 (en) | Oligosaccharide conjugates and methods of use | |
| JP2023549736A (ja) | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 | |
| Vasan et al. | Chemical synthesis and immunological properties of oligosaccharides derived from the vegetative cell wall of Bacillus anthracis | |
| US7527949B2 (en) | Polysaccharides of Helicobacter pylori | |
| JPH05508165A (ja) | Ｈｉｖの処置および予防用ワクチン | |
| WO2011137181A1 (en) | Synthetic oligosaccharides for moraxella vaccine | |
| CN117106041A (zh) | Kdo糖蛋白缀合物及其应用 | |
| HK1232436B (zh) | 用於制备针对因肠致病性细菌引起的感染的广谱疫苗的包含表达内置的多个表位的分子构建体的基本单元的糖缀合物疫苗 | |
| HK1232436A1 (en) | Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria |